PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

8 Oct 2009 15:19

RNS Number : 4870A
J.P. Morgan Private Equity Ltd
08 October 2009
 



Company J.P. Morgan Private Equity Limited 

Headline Final Results

J.P. Morgan Private Equity Limited 

HSBC Private Bank Building, Rue du Pre, St Peter Port, Guernsey GY1 1LU

08 October 2009

Regulatory News Service

London Stock Exchange

London

EC4M 7LS

Dear Sir,

J.P. MORGAN PRIVATE EQUITY LIMITED

Preliminary Announcement of Results for the year ended 30 June 2009.

Dear Sir,

In reviewing the last twelve months leading up to the Company's fourth anniversary, I look back on a year marked by unparalleled challenges and volatility in the global equity and credit markets. From July 2008 through June 2009, almost every industry and asset class experienced rapid devaluations as equity markets fell, credit markets froze and governments were forced to intervene and provide extraordinary assistance to the private sector. These events shook the global markets and reshaped the Company's competitive landscape.

In this year's statement, I would like to address how the Company has responded to the global financial crisis by strengthening its balance sheet and positioning itself to take advantage of the favourable private equity secondary market.

Positioning JPEL's Balance Sheet

Although no one could have anticipated the full impact of the worldwide recession and credit crisis, over the past several quarters, JPEL's Manager has been actively working to strengthen the Company's balance sheet and position the portfolio for an economic downturn. The Manager has focused on building a portfolio of defensive interests that are designed to be well suited to withstand a market correction.

In this regard, the Company has taken the following actions over the past twelve months:

Limited new investment activity: During fiscal year 2009, the Company participated in seven new investments, preferring to be very selective in this market environment.

Reduced unfunded obligations: JPEL has reduced its unfunded commitments by approximately 24% through the sale of selected investments since 31 December 2008.

Raised $130mm of new capital:  The Company raised $111 million of new US$ Equity Shares to take advantage of the current opportunities in the secondary market and to bolster its balance sheet. The Company also raised $12 million through the creation of a new class of Zero Dividend Preference Shares due in 2015 ("2015 ZDP Shares"). I believe that the overwhelming support for these fundraisings demonstrates a tremendous vote of confidence for opportunities available in the secondary private equity market and for JPEL's strategy in general.    

Issued Bonus Warrants in Lieu of June 2009 Redemption Facility: Although the redemption facility was operated for the six-month period ended in December 2008, the Board of Directors elected to temporarily suspend the facility for the six months ended in June 2009. In order to provide shareholders with the opportunity to participate in future potential upside in the Company, JPEL issued 58 million warrants to US$ Equity shareholders on 20 August 2009. 

Going forward, JPEL remains focused on maintaining a strong balance sheet. As such, the operation of the Company's tender facility will be subject to positive net cash flows from the Company's underlying private equity investments and the health of the global economy. In addition, the Company will continue to cautiously invest in the private equity secondary market. 

Core Secondary Investment Strategy

Although fiscal year 2009 resulted in relatively few new investments, the Company has constructed a strong portfolio with defensive characteristics that the Manager believes will be well positioned for a market recovery. JPEL opportunistically made seven investments during fiscal year 2009, focusing on investments in counter-cyclical industries such as education, life sciences and pharmaceuticals.

JPEL's core strategy of buying private equity fund interests in the secondary market and dynamic approach to portfolio management has allowed the Manager to shift the Company's portfolio to take advantage of various investment and market opportunities through the purchase and sale of private equity investments. This strategy has allowed the Manager to construct a portfolio that it believes may retain value in a recessionary environment and will remain poised to target positive performance once markets stabilize:

Defensive industries:  JPEL's Manager has focused on opportunities in counter-cyclical or defensive industries. Approximately 10.5% of the Company's private equity net asset value is invested in education services, with an emphasis on post-secondary education. Pharmaceuticals, Biotechnology and Life Sciences account for 10.8% of the Company's private equity net asset value at 30 June 2009.

Highly diversified: JPEL's private equity portfolio contains exposure to 163 funds in approximately 40 countries with over 1,500 underlying portfolio companies.

Majority of JPEL's portfolio was acquired "post-credit crunch":  Approximately 78% of current private equity NAV was purchased since May 2007 (46% since the beginning of 2008). 

Small buyout focus:  Approximately 44% of JPEL's private equity portfolio is invested in small to medium-sized buyout funds, which tend to utilize lower leverage and purchase multiples.

Special situations investments: Approximately 19% of JPEL's private equity portfolio is invested in special situation funds such as mezzanine, distressed debt and restructuring funds that often benefit from illiquid, contracting markets.

Infrastructure investments: Approximately 6% of JPEL's private equity portfolio is invested in infrastructure-oriented funds, with inherent defensive attributes that may be poised to benefit from increased stimulus packages and government spending.

Deep discounted purchases: JPEL has endeavored to acquire quality companies with "rational" debt levels at deep-discounts to intrinsic value.

Performance

Each of the Company's three classes of shares have enjoyed significant gains in recent months: US$ Equity shares increased 30.6% from 31 March to 30 June 2009, while the 2013 ZDPs and 2105 ZDPs increased by 6.8% and 10.38%, respectively.

Despite recent share price improvements, the Company's performance has not been immune to difficult market conditions. JPEL's 30 June 2009 reported NAV per Equity share was $1.34, down from $1.85 at 30 June 2008 and from $1.44 at the quarter ended 31 March 2009. Approximately 6% of this decline can be attributed to currency fluctuations. It is also important to note that JPEL's 30 June 2009 NAV is based on 31 March 2009 financial reports received from the underlying sponsors. While the equity markets have appreciated in the months following March 2009, the potential benefit of this market rebound for JPEL's NAV has not been reflected in the Company's NAV. 

Much of the decline in private equity valuations can be attributed to a combination of accounting rules, global devaluation in the public equity markets and high usage of leverage in private equity transactions. The implementation of FAS 157, requiring private equity firms to estimate "fair value" based on public market comparables (amongst other factors), combined with the general increase in volatility of the public markets has contributed to the increase in volatility of private company valuations.

JPEL's ZDP Shares continue to perform well. The NAV of 2013 ZDP Shares rose 7.3% during fiscal year 2009, from 51.31p to 55.06p per share. 2013 ZDP Share price has increased 36.6% since inception, closing at 58.75p on 30 June 2009. JPEL's 2015 ZDP Shares, launched on 18 December 2008 have performed well over the preceding 7 months. The NAV of 2015 ZDP Shares rose 4.5% since inception, from 48.75p to 50.93p per share. 2015 ZDP Share price has increased 17.0% since inception, from its offer price of 50p to 58.5p on 30 June 2009.  

Outlook

Fiscal year 2009 was one of the most challenging years in history for the global markets and it is likely that 2010 will continue to bring new challenges. Although equity markets have rallied in recent months, the Manager remains generally cautious about the outlook for the global economy. In this vein, the Manager will continue to focus on maintaining a strong balance sheet and will selectively pursue investments with strong defensive characteristics that have the potential to drive net asset value growth. Despite the volatility in the global markets and unforeseen stresses, I remain confident that JPEL will continue to thrive in this environment and emerge as a strong, well capitalized, market innovator in the listed private equity asset class. 

In conclusion, I would like to thank shareholders for the support and the continued confidence that they have placed in the Company and in its ability to successfully execute its private equity investment strategy. The Company remains focused on seizing the current market opportunities at hand to create value for our shareholders.

Trevor Ash

Chairman

6 October 2009

 

 Consolidated Income Statement
 
For the year ended 30 June 2009

 
 
 
 
2009
 
 
 
2008
 
 
 
£’000
 
 
£’000
Investment income
 
 
 
 
Interest and dividend income
 
4,234
 
4,091
 
 
 
 
 
Expenses
 
 
 
 
 
 
 
 
 
Investment management fee
 
(4,411)
 
(2,728)
Valuers' fees
 
-
 
(26)
Administrative fee
 
(257)
 
(190)
Audit fee
 
(106)
 
(76)
Directors' fees
 
(73)
 
(83)
Performance fee
 
-
 
(1,375)
Other expenses
 
(3,643)
 
(1,474)
 
 
 
 
 
Total Expenses
 
(8,490)
 
(5,952)
 
 
 
 
 
Net loss before finance costs
 
(4,256)
 
(1,861)
 
 
 
 
 
Finance costs
 
 
 
 
Loan interest payable
 
(7,304)
 
(94)
ZDP interest payable
 
(2,505)
 
(3,686)
 
 
 
 
 
Gains/(losses) from investments
 
 
 
 
Net (losses)/gains on investments
 
(105,450)
 
36,701
Realised foreign currency gain/(loss)
 
2,259
 
(678)
Unrealised foreign currency gain
 
4,656
 
3,710
 
 
 
 
 
(Loss)/profit for the year
 
(112,600)
 
34,092
 
 
 
 
 
Attributable to equity holders of the Company
 
(94,892)
 
28,112
Attributable to minority interests
 
(17,708)
 
5,980
 
 
 
 
 
 
 
(112,600)
 
34,092
 
 
 
 
 
Basic and diluted (loss)/earnings per share
 
(34.0p)
 
10.0p

 

Consolidated Balance Sheet
 
As at 30 June 2009

 
 
 
 
2009
 
 
 
2008
 
 
 
£’000
 
 
£’000
Non-current assets
 
 
 
 
Financial assets at fair value through profit or loss
 
369,836
 
374,159
 
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
 
17,862
 
13,789
Receivables
 
552
 
2,092
 
 
 
 
 
 
 
18,414
 
15,881
Current liabilities
 
 
 
 
Payables and accruals
 
(8,323)
 
(6,332)
Derivative financial instruments
 
(289)
 
(255)
 
 
 
 
 
Net current assets
 
9,802
 
9,294
 
 
 
 
 
Non-current liabilities
 
 
 
 
Loan
 
(101,973)
 
(59,875)
Zero dividend preference shares
 
(43,085)
 
(30,375)
 
 
(145,058)
 
(90,250)
 
 
 
 
 
Net Assets
 
234,580
 
293,203
 
 
 
 
 
 
 
 
 
 
Represented by:
 
 
 
 
 
 
 
 
 
Share capital
 
188,049
 
29
Reserves
 
34,503
 
270,307
 
 
 
 
 
Total equity attributable to equity holders of the
Company
 
 
222,552
 
 
270,336
 
 
 
 
 
Minority interest
 
12,028
 
22,867
 
 
 
 
 
Total equity
 
234,580
 
293,203
 
 
 
 
 
NAV per Equity share
 
£0.81
 
£0.92
 

 

 

Consolidated Cash Flow Statement

For the year ended 30 June 2009

 

 Notes

2009

2008

£'000

£'000

 

Operating activities

(Loss)/profit for the year

(112,600)

34,092

Adjustments for:

Interest and dividend income

(4,234)

(4,091)

Interest expense

9,809

3,780

Tax rebates/(payments)

99

(577)

Net derivative (gains)/losses

(10,699)

3,360

Net losses/(gains) on investments

111,046

(41,237)

Net losses on disposal of investments

5,104

-

Unrealised foreign currency gain

(4,656)

(3,371)

Operating cash flows before changes in working capital 

(6,131)

(8,044)

 

Decrease/(increase) in receivables

1,502

(2,338)

Increase in payables

1,549

1,618

Net cash movement in derivative contracts

11,709

(1,980)

Cash flows from operating activities

8,629

(10,744)

 

Investing activities

Purchase of investments 

(86,046)

(141,571)

Net proceeds from sale of non-current financial assets

54,593

35,356

Interest received

1,607

2,915

Other income distributions from investments

3,056

1,176

Acquisition of subsidiary net of cash received

-

(50,355)

Cash flows from investing activities

(26,790)

(152,479)

 

Financing activities 

Proceeds on issue of equity shares

-

7,635

Equity shares buy back

(31,272)

(3,562)

Issue costs

(45)

(263)

Loans received

43,352

25,852

Loans paid

(7,847)

-

Interest paid

(7,635)

(1,619)

Issue of shares in subsidiary to minority interest

1,746

7,748

Acquisition of minority interest

(415)

-

Treasury purchases

-

(21,229)

Proceeds from treasury share sale

10,828

20,307

Cost of redemption of zero divided preference shares

(1,743)

(137)

Proceeds from issue of zero divided preference shares

11,720

-

Distributions to minority interest

(457)

-

Cash flows from financing activities

18,232

34,732

 

Net increase/(decrease) in cash and cash equivalents

71

(128,491)

Cash and cash equivalents at beginning of year

13,789

132,177

Effects of exchange difference arising from cash and cash equivalents

4,002

10,103

Cash and cash equivalents at end of the year

17,862

13,789

Consolidated Statement of Changes in Equity

For the year ended 30 June 2009

 

Share Capital Account £'000

Share Premium £'000

Accumulated Losses

£'000

Capital Reserve £'000

Currency Translation Reserve £'000

Capital Redemption Reserve £'000

Special Distributable Reserve £'000

Total £'000

Minority Interest £'000

Total £'000

At 1 July 2008

29

7,636

(4,829)

69,838

(3,211)

4

200,869

270,336

22,867

293,203

Transfer 

208,509

(7,636)

-

-

-

(4)

(200,869)

-

-

-

Share buy backs

(31,272)

-

-

-

-

-

-

(31,272)

-

(31,272)

Treasury sale

10,828

-

-

-

-

-

-

10,828

-

10,828

Share issue costs

(45)

-

-

-

-

-

-

(45)

-

(45)

Loss for the year

-

-

(4,746)

(90,146)

-

-

-

(94,892)

(17,708)

(112,600)

Effect of translation of presentation currency

-

-

-

-

67,597

-

-

67,597

5,535

73,132

Issue of shares in subsidiary to minority interests

-

-

-

-

-

-

-

-

1,746

1,746

Minority interest ceded

-

-

-

-

-

-

-

-

(412)

(412)

At 30 June 2009

188,049

-

(9,575)

(20,308)

64,386

-

-

222,552

12,028

234,580

  Consolidated Statement of Changes in Equity

For the year ended 30 June 2008

 

Share Capital Account £'000

Share Premium £'000

Accumulated Losses

£'000

Capital Reserve £'000

Currency Translation Reserve £'000

Capital Redemption Reserve £'000

Special Distributable Reserve £'000

Total £'000

Minority Interest £'000

Total £'000

At 1 July 2007

29

154,329

(6,590)

43,487

(11,546)

1

51,291

231,001

6,059

237,060

Transfer to special distributable reserve

-

(154,329)

-

-

-

-

154,329

-

-

-

Issue of equity shares

1

7,634

-

-

-

-

-

7,635

-

7,635

Redemption of equity shares

-

-

-

-

-

-

(3,562)

(3,562)

-

(3,562)

Transfer to capital redemption reserve

-

-

-

-

-

3

(3)

-

-

-

Transfer to capital reserve

-

-

3,398

(3,398)

-

-

-

-

-

-

Issue Costs

-

(263)

-

-

-

-

-

(263)

(263)

30

7,371

(3,192)

40,089

(11,546)

4

202,055

234,811

6,059

240,870

Share buy backs

(3)

-

-

-

-

-

(21,226)

(21,229)

-

(21,229)

Treasury share sale

2

265

-

-

-

-

20,040

20,307

-

20,307

Net movement in treasury shares

(1)

265

-

-

-

-

(1,186)

(922)

-

(922)

Profit for the period

-

-

(1,637)

29,749

-

-

-

28,112

5,980

34,092

Effect of translation of presentation currency

-

-

-

-

8,335

-

-

8,335

2,046

10,381

Issue of shares in subsidiary to minority interests

-

-

-

-

-

-

-

-

7,748

7,748

Minority interest acquired in Group combination

-

-

-

-

-

-

-

-

1,034

1,034

At 30 June 2008

29

7,636

(4,829)

69,838

(3,211)

4

200,869

270,336

22,867

293,203

The above financial information does not constitute statutory financial statements as defined in Section 262 of The Companies (Guernsey) Law, 2008. The comparative information is based on the statutory financial statements for the year ended 30 June 2008. Those financial statements, upon which the auditors issued an unqualified opinion, have been delivered to the Registrar of Companies. Statutory financial statements for the year ended 30 June 2009 will be delivered to the Registrar of Companies in due course.

Copies of the Annual Report will be sent to Members in the last week of October 2009 and will be available to members of the public from the Registered office at St Martins House, Le Bordage, St Peter Port, Guernsey GY1 1BP.

Trevor Ash

Chairman

06 October 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR MPBITMMMMBRL
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.